News News
Contact us
  • Customer service number:64321087
  • Commercial service telephone:13918059423
  • Technical service telephone:13918059423
  • Contact person: Mr. Cui 
  • Service email:shxtb@163.com
  • Address: room 107, building 8, no. 100, guilin road, xuhui district, Shanghai

Multifunctional YHM shows promise for diagnosis and treatment of orthotopic glioma

The date of: 2022-05-07
viewed: 3
source: News medical


Glioma is an intracranial malignant tumor that still poses a major clinical challenge due to its highly invasive nature, low cure rate, and high mortality rate. Although advanced molecular imaging techniques, such as magnetic resonance imaging (MRI) and computed tomography (CT) can be used for glioma diagnosis, their low spatial resolution, harmful ionization, and complicated workflow limit their application in real-time intraoperative imaging.
In a new paper published in Light Science & Application, a team of scientists, led by Professor Hongjie Zhang and Professor Yinghui Wang from State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry (CIAC), Chinese Academy of Sciences, China, Jianhua Liu from Department of Radiology, The Second Hospital of Jilin University, China, and co-workers have developed a core-shell structured nanotheranostic agent (YVO4:Nd3+-HMME@MnO2-LF, marked as YHM) with YVO4:Nd3+ particles as the core and MnO2 nanosheets as the shell. Sonosensitizer hematoporphyrinmonomethyl ether (HMME) and lactoferrin (LF) were further loaded and modified on the surface, giving it a good ability to cross the BBB, near-infrared fluorescence imaging in the second window (NIR-II)/MRI bimodality, and highly efficient sonodynamic therapy (SDT) of orthotopic gliomas. The YVO4:Nd3+ core exhibited good NIR-II fluorescence properties, enabling YHM to act as promising probes for NIR-II fluorescence imaging of vessels and orthotopic gliomas. The MnO2 shell can not only provide O2 in the tumor microenvironments (TME) to significantly improve the healing efficacy of SDT, but also release Mn2+ ions to achieve T1-weight MRI in situ. Non-invasive SDT can effectively restrain tumor growth. This work not only demonstrates that multifunctional YHM is promising for diagnosis and treatment of orthotopic glioma, but also provides insights into exploring the theranostic agents based on rare earth-doped yttrium vanadate nanoparticles.



Hot News / Related to recommend
  • 2025 - 07 - 08
    Click on the number of times: 0
    来源:ACS PublicationsA straightforward synthesis of Cp*2Sc(AlMe4) (Cp* = C5Me5) applying Cp*2ScCl(thf) and LiAlMe4/AlMe3 is described. Donor-assisted trimethyltriel exchange gives access to Cp*2Sc(EMe4)...
  • 2025 - 07 - 07
    Click on the number of times: 0
    Zero-Field Single Molecular Magnet Behavior of Selenotungstate-Encapsulated Dy(III) Tetramers 来源:ACS PublicationsTwo tartaric acid-bridged organic–inorganic hybrid Dy(III)-substituted selenotungs...
  • 2025 - 07 - 04
    Click on the number of times: 0
    来源:ACS PublicationsThe AM2Pn2 (A= Ca, Sr, Ba, Yb, Mg; M = Zn, Cd, Mg; and Pn = N, P, As, Sb, Bi) family of Zintl phases has been known as thermoelectric materials and has recently gained much attentio...
  • 2025 - 07 - 03
    Click on the number of times: 1
    Defects and Defect Association Determine the Actual Entropy of Perovskites Derived from Lanthanum–Calcium Ferrite来源:ACS PublicationsPerovskites La1/2Ca1/2Mn1/3Fe1/3Co1/3O3−δ and iron-rich La3/4Ca1/4Mn...
  • Copyright ©Copyright 2018 2020 Shanghai rare earth association All Rights Reserved Shanghai ICP NO.2020034223
    the host:Shanghai Association of Rare Earth the guide:Shanghai Development and Application Office of Rare Earth the organizer:Shanghai rare earth industry promotion center
    犀牛云提供云计算服务